Ads

 

Ads

 

Ads

 

Top Healthcare Companies in China List by Market Cap as on July-30-2023

Top Healthcare Companies in China List by Market Cap as on July-30-2023. Biggest and Top Healthcare Companies in China Companies by Market Cap. Largest Top Healthcare Companies in China List by Market Cap as on July-30-2023.
Metatag Title
Top Healthcare Companies in China,
Metatag Abstract
Top Healthcare Companies in China, Biggest Healthcare Companies in China, Largest Healthcare Companies in China.
  1. Jiangsu Hengrui Medicine

    World Rank (Jan-05-2024)
    477
    Market Cap (Jan-05-2024)
    37.964 Billion USD
    World Rank (Jul-30-2023)
    419
    Market Cap (Jul-30-2023)
    43.773 Billion USD
    World Rank (Dec-25-2022)
    502
    Market Cap (Dec-25-2022)
    33.556 Billion USD
    World Rank (Jan-07-2022)
    375
    Market Cap (Jan-07-2022)
    51.00 Billion USD
    Annual Revenue in USD
    2,976 Million USD
    Annual Operating Income in USD
    468 Million USD
    Annual Net Income in USD
    546 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Jiangsu Hengrui Medicine is Pharmaceutical company based in China and it is one of largest manufactures of Antineoplastic. Headquarters is in China.

  2. Wuxi Apptec

    World Rank (Jan-05-2024)
    639
    Market Cap (Jan-05-2024)
    28.713 Billion USD
    World Rank (Jul-30-2023)
    657
    Market Cap (Jul-30-2023)
    28.840 Billion USD
    World Rank (Dec-25-2022)
    517
    Market Cap (Dec-25-2022)
    32.132 Billion USD
    World Rank (Jan-07-2022)
    386
    Market Cap (Jan-07-2022)
    50.14 Billion USD
    Annual Revenue in USD
    5,506 Million USD
    Annual Operating Income in USD
    1,364 Million USD
    Annual Net Income in USD
    1,233 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    WUXI APPTEC is a pharmaceutical and biotechnology company with headquarters is in China.

    As on 2022, Wuxi AppTec has 29 sites worldwide and more than 44,361 employees globally. Wuxi today provides a broad portfolio of R&D and manufacturing services that support over 4,100 collaborative partners worldwide.

  3. Aier Eye Hospital Group

    World Rank (Jan-05-2024)
    939
    Market Cap (Jan-05-2024)
    19.290 Billion USD
    World Rank (Jul-30-2023)
    701
    Market Cap (Jul-30-2023)
    26.453 Billion USD
    World Rank (Dec-25-2022)
    542
    Market Cap (Dec-25-2022)
    30.961 Billion USD
    World Rank (Jan-07-2022)
    635
    Market Cap (Jan-07-2022)
    32.81 Billion USD
    Annual Revenue in USD
    2,254 Million USD
    Annual Operating Income in USD
    562 Million USD
    Annual Net Income in USD
    353 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    AIER Eye Hospital Group is China's ophthalmology hospital group that covers Asia, Europe, and North America with huge scale and outstanding medical capacity. It has three listed companies in China (stock code: 300015) , Europe (Spain: CBAV), and Southeast Asia (Singapore: 40T) with a total number of more than 600 specialized eye hospitals and centers and the annual outpatient visits in mainland China exceeded 10 million.

  4. Zhangzhou Pientzehuang Pharmaceutical. Ltd

    World Rank (Jan-05-2024)
    914
    Market Cap (Jan-05-2024)
    20.016 Billion USD
    World Rank (Jul-30-2023)
    770
    Market Cap (Jul-30-2023)
    24.483 Billion USD
    World Rank (Dec-25-2022)
    673
    Market Cap (Dec-25-2022)
    25.005 Billion USD
    World Rank (Jan-07-2022)
    549
    Market Cap (Jan-07-2022)
    37.28 Billion USD
    Annual Revenue in USD
    1,216 Million USD
    Annual Operating Income in USD
    400 Million USD
    Annual Net Income in USD
    346 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Zhangzhou Pien Tze Huang Pharmaceutical Co Ltd is a Pharmaceutical company. The company has 34 holding subsidiaries, 8 joint stock companies and 4 industry funds with more than 2,100 employees. The headquarters is in China.
  5. Wuxi Biologics (Cayman)

    World Rank (Jan-05-2024)
    1,181
    Market Cap (Jan-05-2024)
    14.971 Billion USD
    World Rank (Jul-30-2023)
    804
    Market Cap (Jul-30-2023)
    23.456 Billion USD
    World Rank (Dec-25-2022)
    579
    Market Cap (Dec-25-2022)
    29.224 Billion USD
    World Rank (Jan-07-2022)
    456
    Market Cap (Jan-07-2022)
    43.63 Billion USD
    Annual Revenue in USD
    2,136 Million USD
    Annual Operating Income in USD
    671 Million USD
    Annual Net Income in USD
    618 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    WuXi Biologics is a biotechnology company related to global Contract Research, Development and manufacturing offering end-to-end solutions that enable partners to discover, develop and manufacture biologics.  Headquarters is in China.

  6. Chongqing Zhifei Biological Products

    World Rank (Jan-05-2024)
    938
    Market Cap (Jan-05-2024)
    19.341 Billion USD
    World Rank (Jul-30-2023)
    1,096
    Market Cap (Jul-30-2023)
    16.721 Billion USD
    World Rank (Dec-25-2022)
    855
    Market Cap (Dec-25-2022)
    19.561 Billion USD
    World Rank (Jan-07-2022)
    729
    Market Cap (Jan-07-2022)
    28.64 Billion USD
    Annual Revenue in USD
    5,353 Million USD
    Annual Operating Income in USD
    1,301 Million USD
    Annual Net Income in USD
    1,055 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Chongqing Zhifei Biological Products is Biotechnology company with nearly 3,000 employees, and assets of 13.6 billion yuan.

    In 2019, it achieved operating income of 10.59 billion yuan.

  7. Yunnan Baiyao Group

    World Rank (Jan-05-2024)
    1,396
    Market Cap (Jan-05-2024)
    12.384 Billion USD
    World Rank (Jul-30-2023)
    1,300
    Market Cap (Jul-30-2023)
    13.647 Billion USD
    World Rank (Dec-25-2022)
    1,130
    Market Cap (Dec-25-2022)
    14.223 Billion USD
    World Rank (Jan-07-2022)
    1,009
    Market Cap (Jan-07-2022)
    20.58 Billion USD
    Annual Revenue in USD
    5,105 Million USD
    Annual Operating Income in USD
    582 Million USD
    Annual Net Income in USD
    420 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Pharmaceutical Company with headquarters is in China. Manufactures medicines and chemicals.
  8. Huadong Medicine Co. Ltd

    World Rank (Jan-05-2024)
    1,738
    Market Cap (Jan-05-2024)
    9.445 Billion USD
    World Rank (Jul-30-2023)
    1,538
    Market Cap (Jul-30-2023)
    11.214 Billion USD
    World Rank (Dec-25-2022)
    1,407
    Market Cap (Dec-25-2022)
    11.120 Billion USD
    World Rank (Jan-07-2022)
    1,625
    Market Cap (Jan-07-2022)
    11.90 Billion USD
    Annual Revenue in USD
    5,276 Million USD
    Annual Operating Income in USD
    464 Million USD
    Annual Net Income in USD
    350 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Huadong Medicine Co.Ltd is specializes in the production and sales of antibiotic, Chinese patent medicine, synthetic drug, genetic engineering drugs as well as wholesale business of Chinese and western medicine, Chinese herbal medicines, medical apparatus and instruments. The company annual revenue is 5.11 billion USD and 1,056 employees as on 2019. The headquarters is in China.
  9. Shanghai Fosun Pharmaceutical (Group)

    World Rank (Jan-05-2024)
    1,904
    Market Cap (Jan-05-2024)
    8.479 Billion USD
    World Rank (Jul-30-2023)
    1,572
    Market Cap (Jul-30-2023)
    10.928 Billion USD
    World Rank (Dec-25-2022)
    1,219
    Market Cap (Dec-25-2022)
    13.054 Billion USD
    World Rank (Jan-07-2022)
    1,185
    Market Cap (Jan-07-2022)
    17.18 Billion USD
    Annual Revenue in USD
    6,149 Million USD
    Annual Operating Income in USD
    509 Million USD
    Annual Net Income in USD
    522 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Pharmaceutical company with headquarters is in China.
  10. Hansoh Pharmaceutical Group Company

    World Rank (Jan-05-2024)
    1,567
    Market Cap (Jan-05-2024)
    10.603 Billion USD
    World Rank (Jul-30-2023)
    1,673
    Market Cap (Jul-30-2023)
    10.026 Billion USD
    World Rank (Dec-25-2022)
    1,472
    Market Cap (Dec-25-2022)
    10.548 Billion USD
    World Rank (Jan-07-2022)
    1,474
    Market Cap (Jan-07-2022)
    13.59 Billion USD
    Annual Revenue in USD
    1,315 Million USD
    Annual Operating Income in USD
    391 Million USD
    Annual Net Income in USD
    362 Million USD
    Annual Results for Period Ending
    Dec-2022 ending period
    Headquarters Country
    Company Profile
    HANSOH PHARMACEUTICAL GROUP COMPANY is a pharmaceutical company with headquarters is in China.

Share

Ads